OSL:CONTX - Oslo Bors ASA - SE0014731154 - Common Stock - Currency: NOK
CONTEXTVISION AB
OSL:CONTX (2/4/2025, 7:00:00 PM)
5.08
-0.1 (-1.93%)
The current stock price of CONTX.OL is 5.08 NOK. In the past month the price decreased by -8.96%. In the past year, price decreased by -43.56%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 37.14 | 36.66B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.58 | 1.23B | ||
NXU.DE | NEXUS AG | 44.26 | 1.18B | ||
EQS.PA | EQUASENS | 11.81 | 555.22M | ||
GPI.MI | GPI SPA | 3 | 276.67M | ||
CGM.PA | CEGEDIM SA | 80 | 169.20M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 138.25M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 61.94M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
AJ91.DE | DOCCHECK AG | 18.65 | 45.38M | ||
ALINS.PA | INTRASENSE SAS | N/A | 14.21M |
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 41 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
CONTEXTVISION AB
Hollandargatan 13, 2 tr
Stockholm STOCKHOLM SE
Employees: 41
Company Website: https://www.contextvision.com/
Investor Relations: https://www.contextvision.com/investors/
Phone: 4687503550
The current stock price of CONTX.OL is 5.08 NOK.
The exchange symbol of CONTEXTVISION AB is CONTX and it is listed on the Oslo Bors ASA exchange.
CONTX.OL stock is listed on the Oslo Bors ASA exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CONTX.OL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CONTX.OL.
CONTX.OL has a dividend yield of 4.18%. The yearly dividend amount is currently 0.3.
CONTX.OL will report earnings on 2025-02-20, after the market close.
The PE ratio for CONTX.OL is 18.14. This is based on the reported non-GAAP earnings per share of 0.28 and the current share price of 5.08 NOK.
ChartMill assigns a technical rating of 1 / 10 to CONTX.OL. When comparing the yearly performance of all stocks, CONTX.OL is a bad performer in the overall market: 90.6% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL. CONTX.OL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months CONTX.OL reported a non-GAAP Earnings per Share(EPS) of 0.28. The EPS decreased by -43.75% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.76% | ||
ROA | 18.29% | ||
ROE | 22.76% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 84% to CONTX.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -28.88% and a revenue growth -5.88% for CONTX.OL